IMMUNOSTEALTH Trademark

Trademark Overview

On Thursday, August 19, 2021, a trademark application was filed for IMMUNOSTEALTH with the United States Patent and Trademark Office. The USPTO has given the IMMUNOSTEALTH trademark a serial number of 90891744. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, August 27, 2024. This trademark is owned by Shoreline Biosciences, Inc.. The IMMUNOSTEALTH trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical or clinical use; biological preparations intended for medical and clinical use, namely, the treatment of cancer, autoimmune diseases, viral infections, and degenerative diseases
immunostealth

General Information

Serial Number90891744
Word MarkIMMUNOSTEALTH
Filing DateThursday, August 19, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, August 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements

Goods and ServicesCells for medical or clinical use; biological preparations intended for medical and clinical use, namely, the treatment of cancer, autoimmune diseases, viral infections, and degenerative diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameShoreline Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameShoreline Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, September 27, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 23, 2021NEW APPLICATION ENTERED
Monday, September 27, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 27, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 20, 2022ASSIGNED TO EXAMINER
Tuesday, November 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 28, 2022NON-FINAL ACTION WRITTEN
Saturday, May 28, 2022NON-FINAL ACTION E-MAILED
Saturday, May 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 23, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 7, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 21, 2024SOU EXTENSION 2 GRANTED
Thursday, September 7, 2023SOU EXTENSION 1 FILED
Thursday, September 7, 2023SOU EXTENSION 1 GRANTED
Saturday, September 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 21, 2024SOU EXTENSION 2 FILED
Wednesday, February 21, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 27, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 27, 2024SOU EXTENSION 3 FILED
Tuesday, August 27, 2024SOU EXTENSION 3 GRANTED

Related Keywords

immunostealth diseases clinical medical autoimmune viral degenerative cancer infections namely biological